Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Osteoarthrosis | Case report

Hip osteoarticular complication due to delay in diagnosis and treatment of brucellar hip arthritis: two cases report

Authors: Jie He, Qiang Zhang

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Brucellosis is a systemic infectious disease frequently associated with osteoarticular involvement. While sacroiliitis is a common manifestation of brucellosis, septic osteoarthritis is less frequent. Here, we report two cases of septic osteoarthritis caused by Brucella melitensis.

Case presentation

Both patients had a history of contact with goats before admission. Upon clinical examination, they showed marked pain and limited movement in the hip. Imaging findings revealed obvious osteonecrosis of the right femoral head. Inflammatory markers, including erythrocyte sedimentation rate and C-reactive protein level, were elevated. The tube agglutination test results of both patients were positive (1:160 and 1:200). Real-time polymerase chain reaction analysis of synovial fluid revealed the presence of B. melitensis. We deduced that septic osteoarthritis could explain these clinical and radiological findings. Both patients were followed-up for 12 months. They returned to their normal routine after completing a standard antibiotic regimen, including doxycycline (100 mg, daily) and rifampicin (600 mg), for 6 weeks.

Conclusions

Brucellar hip arthritis is a serious clinical manifestation of brucellosis, presenting mainly as marked joint pain and limited mobility. It is characterized by joint effusion, synovitis, and soft-tissue swelling on magnetic resonance images. Physicians should consider brucellosis as one of the differential diagnoses of arthritis.
Literature
1.
go back to reference Zhong Z, Yu S, Wang X, Dong S, Xu J, Wang Y, Chen Z, Ren Z, Peng G. Human brucellosis in the People’s Republic of China during 2005–2010. Int J Infect Dis. 2013;17:e289–92.CrossRef Zhong Z, Yu S, Wang X, Dong S, Xu J, Wang Y, Chen Z, Ren Z, Peng G. Human brucellosis in the People’s Republic of China during 2005–2010. Int J Infect Dis. 2013;17:e289–92.CrossRef
2.
go back to reference Bosilkovski M, Rodriguez-Morales AJ. Brucellosis and its particularities in children travelers. Recent Pat Antiinfect Drug Discov. 2014;9:164–72.CrossRef Bosilkovski M, Rodriguez-Morales AJ. Brucellosis and its particularities in children travelers. Recent Pat Antiinfect Drug Discov. 2014;9:164–72.CrossRef
3.
go back to reference Turan H, Serefhanoglu K, Karadeli E, Togan T, Arslan H. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern Med. 2011;50:421–8.CrossRef Turan H, Serefhanoglu K, Karadeli E, Togan T, Arslan H. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern Med. 2011;50:421–8.CrossRef
5.
go back to reference Bosilkovski M, Krteva L, Caparoska S. Hip arthritis in brucellosis: a study of 33 cases in the Republic of Macedonia (FYROM). Int J Clin Pract. 2004;58:1023–7.CrossRef Bosilkovski M, Krteva L, Caparoska S. Hip arthritis in brucellosis: a study of 33 cases in the Republic of Macedonia (FYROM). Int J Clin Pract. 2004;58:1023–7.CrossRef
8.
go back to reference Khateeb MI, Araj GF, Majeed SA. Brucella arthritis: a study of 96 cases in Kuwait. Ann Rheum Dis. 1990;49:994–8.CrossRef Khateeb MI, Araj GF, Majeed SA. Brucella arthritis: a study of 96 cases in Kuwait. Ann Rheum Dis. 1990;49:994–8.CrossRef
10.
go back to reference Hasanjani Roushan MR, Marashi SM. Polymerase Chain Reaction-Based Assays for the Diagnosis of Active and Relapsed Cases of Human Brucellosis. Am J Trop Med Hyg. 2016;95:1272–6.CrossRef Hasanjani Roushan MR, Marashi SM. Polymerase Chain Reaction-Based Assays for the Diagnosis of Active and Relapsed Cases of Human Brucellosis. Am J Trop Med Hyg. 2016;95:1272–6.CrossRef
12.
go back to reference Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336:701–4.CrossRef Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336:701–4.CrossRef
13.
go back to reference Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the twenty-first century: the Ioannina recommendations. PLoS Med. 2007;4:e317.CrossRef Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the twenty-first century: the Ioannina recommendations. PLoS Med. 2007;4:e317.CrossRef
Metadata
Title
Hip osteoarticular complication due to delay in diagnosis and treatment of brucellar hip arthritis: two cases report
Authors
Jie He
Qiang Zhang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4045-9

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.